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Activation-induced cytidine 
deaminase targets SUV4-
20-mediated histone H4K20 
trimethylation to class-switch 
recombination sites
Virginia C. Rodríguez-Cortez1, Paloma Martínez-Redondo2, Francesc Catal-Moll1, Javier 
Rodríguez-Ubreva1, Antonio Garcia-Gomez1, Ganesh Poorani-Subramani3,4, Laura Ciudad1, 
Henar Hernando1, Arantxa Pérez-García5, Carlos Company1, José M. Urquiza1, Almudena R. 
Ramiro5, Javier M. Di Noia3,4,6, Alejandro Vaquero  2 & Esteban Ballestar1
Activation-induced cytidine deaminase (AID) triggers antibody diversification in B cells by catalysing 
deamination and subsequently mutating immunoglobulin (Ig) genes. Association of AID with RNA Pol 
II and occurrence of epigenetic changes during Ig gene diversification suggest participation of AID in 
epigenetic regulation. AID is mutated in hyper-IgM type 2 (HIGM2) syndrome. Here, we investigated 
the potential role of AID in the acquisition of epigenetic changes. We discovered that AID binding to 
the IgH locus promotes an increase in H4K20me3. In 293F cells, we demonstrate interaction between 
co-transfected AID and the three SUV4-20 histone H4K20 methyltransferases, and that SUV4-20H1.2, 
bound to the IgH switch (S) mu site, is replaced by SUV4-20H2 upon AID binding. Analysis of HIGM2 
mutants shows that the AID truncated form W68X is impaired to interact with SUV4-20H1.2 and SUV4-
20H2 and is unable to bind and target H4K20me3 to the Smu site. We finally show in mouse primary 
B cells undergoing class-switch recombination (CSR) that AID deficiency associates with decreased 
H4K20me3 levels at the Smu site. Our results provide a novel link between SUV4-20 enzymes and CSR 
and offer a new aspect of the interplay between AID and histone modifications in setting the epigenetic 
status of CSR sites.
Activation-induced cytidine deaminase (AID; gene symbol AICDA) is a key enzyme in B cell biology because 
it is needed to generate immunoglobulin (Ig) diversification by inducing class switch recombination (CSR) and 
somatic hypermutation (SHM)1. AID initiates SHM and CSR by deaminating cytosines to uracils. This leads 
to the generation of dU:dG mismatches that are differentially processed to generate double-strand breaks in Ig 
switch regions in CSR and point mutations in Ig variable regions during SHM. However, AID is also expressed 
in a variety of germ and somatic cells and there is evidence of additional roles. For instance, AID is homologous 
to the well-characterised RNA-editing enzyme APOBEC1, and its participation in RNA editing of viral genomes, 
perhaps in conjunction with an unknown cofactor, has been suggested2. AID can also deaminate numerous 
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non-immunoglobulin genes, including CD79A, MYC and PAX53–6. The basis of the off-target deamination ability 
of AID are not fully understood but include its preference to interact with H3K27Ac-rich superenhancers6.
A variety of studies have demonstrated different connections between AID and epigenetic modifications at 
its binding sites. For instance, KAP1 and HP1 tether AID to H3K9me3 residues at the donor switch region7. 
Additionally, 14-3-3 adaptors proteins directly interact with AID and target it to the selected S regions, where 
14-3-3 promotes recombination through the recognition of the open chromatin state in these S regions and its 
specific binding to phospho Ser10 and acetyl Lys9 histone H38. Also, the presence of H3.3 in the nucleosomes of 
the Ig variable regions promotes the generation of AID-accessible single-stranded DNA that promotes Ig diver-
sification9. AID-deficient mice have significantly lower levels of histone acetylation in S regions than observed in 
WT mice, implying a relationship between AID expression and histone modification enzymes10. It has also been 
proposed that AID’s catalytic activity, which mediates the conversion of cytosines to uracils, may participate in the 
removal of methylated cytosines as a two-step mechanism leading to active demethylation. In this context, AID 
would result in demethylating and activating critical pluripotency genes, OCT4 and NANOG, during reprogram-
ming of somatic cells to pluripotent stem cells11. Despite these findings, the involvement of AID in active DNA 
demethylation seems to be restricted to specific scenarios12, and it remains controversial in the B cell context13, 14.
AID deficiency causes hyper-IgM type 2 (HIGM2) syndrome15, which is characterised by the absence of 
immunoglobulin CSR and SHM. The study of natural AID mutants associated with HIGM2 as well as engineered 
mutants has led to the characterisation of the active domains of the protein. AID, through its cytidine deaminase 
activity, induces targeted DNA lesions required for both CSR and SHM. Besides its cytidine deaminase activity, 
AID plays a further essential role in CSR, probably through the recruitment of CSR-specific cofactors by its 
C-terminus16, 17. A similar binding of SHM-specific cofactors to the N-terminal part is suggested by the functional 
characteristics of N-terminal AID artificial mutants. Finally, AID may act as a homo-, di-, or multimeric com-
plex18. Together, these findings strongly suggest that AID acts on CSR not only as a cytidine deaminase enzyme, 
but also as a docking protein, recruiting specific cofactors to a multimeric complex. These interactions probably 
also include epigenetic enzymes and influence the epigenetic status of AID target sites, preparing the chromatin 
context for efficient CSR and SHM, and perhaps directly regulating its transcriptional status.
In the study reported here, we investigated the effects of AID on the epigenetic status of its binding sites, 
including the analysis of DNA methylation and several histone modifications. We observed a sharp increase 
in H4K20me3 at Sμ sites, which are also detected at the global level. In 293F cells, we demonstrated a physical 
interaction between co-transfected tagged AID and the SUV4-20H1 and SUV4-20H2 enzymes, involved in the 
dimethylation and trimethylation of H4K20. We also show that AID exchanges SUV4-20H1 and SUV4-20H2 at 
Sμ sites. The analysis of HIGM2 mutants of AID reveals that the truncated form W68X is impaired for efficient 
binding with SUV4-20H1 and SUV4-20H2 and H4K20me3 is no longer targeted to Sμ sites. Most importantly, 
we show that mouse primary B cells activated for CSR with LPS + IL4 undergo an increase in H4K20me3 that 
does not occur in AID-deficient mice. A similar association between AID and H4K20me3 levels at Sμ in B cells 
is obtained in CH12F3-2 cells, when they are depleted of AID and subsequently re-transfected with AID. Our 
results demonstrate for the first time the AID-dependent recruitment of SUV4-20 enzymes at Ig switch regions 
and suggest a direct interaction with AID, providing a novel link between these two enzymes that explains the 
effects on CSR of abrogating Suv4-20h enzymes in mice19.
Results
AID preferentially associates with heterochromatin. To investigate the ability of AID to target epige-
netic modifications at its cognate sites in B cells, and how these changes may be impaired in HIGM2 individuals, 
we first generated an inducible retroviral system to express wild type AID (Fig. 1A). We selected two cell types, 
Jiyoye and HeLa, for our experiments. Jiyoye cells, which are Burkitt lymphoma-derived B cells, are a B cell model 
in which AID is not expressed. HeLa cells have been used for many biochemical studies of human AID and are 
ideal for testing the cell distribution by immunofluorescence. For the inducible system, we chose to infect Jiyoye 
and HeLa cells with the RetroX-Tet-ON advanced vector with geneticin resistance, followed by transduction with 
the pRetroX-Tight-Pur vector encoding AID tagged with HA at its C-t. AID was expressed following the addition 
of doxycycline (Fig. 1B). To ensure the accumulation of AID in the cell nucleus, nuclear export was inhibited 
by the addition of leptomycin B, as previously described20. As expected, we observed nuclear accumulation of 
AID-HA after leptomycin B treatment in Jiyoye and HeLa cells (Fig. 1C).
To determine whether the bulk of AID is associated with heterochromatin or euchromatin we performed an 
endonuclease digestion-based assay21 to compare the ability of AID to be released from chromatin with euchro-
matic (H3Ac and H3K4me3) and facultative heterochromatic (H3K27me3) and constitutive heterochromatic 
(H4K20me3) histone modifications. Using this assay strategy we observed that euchromatic histone modifica-
tions are released following digestion and are apparent in the supernatant after 2–4 min of digestion, whereas 
constitutive heterochromatic marks remain mostly in the insoluble fraction after long digestion. In this assay, 
AID displayed a similar behaviour to that seen in H4K20me3 (Fig. 1D), suggesting that it is associated with these 
modifications in the constitutive heterochromatin compartment.
AID expression results in an increase in H4K20me3 at Switch repeats of the IGH locus. CSR and 
SHM both depend on AID activity and its direct binding to specific sites at the Ig genes. To initiate productive 
CSR, AID-induced double-strand breaks (DSBs) must occur at the switch (S) repeat regions of the IGH locus that 
precede the participating constant (C) region gene segments (Fig. 2A and Supplementary Figure 1A). These are 
very well defined sequences that enable us to investigate the potential effect of AID on their epigenetic status. In 
this analysis, we first investigated the binding of AID to the Sμ segment in the two inducible cell models. ChIP 
assays revealed specific binding of AID to the Sμ following induction of expression and a further increase after 
inhibition of nuclear export. AID enrichment at the Sμ region could be observed in HeLa cells but was 8-10-fold 
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higher in Jiyoye B cells, presumably because the IGH is much more strongly transcribed in the latter than the 
former. This binding did not occur at the Cμ sequence in Jiyoye cells and only to a limited extent in HeLa cells 
(Fig. 2C, left panel). To test the potential effect of AID on DNA methylation, we performed bisulphite pyrose-
quencing of specific CpG sites located within the Sμ and Cμ regions (Fig. 2A). We found no changes in the DNA 
methylation levels at either the Cμ region or the Sμ site, where AID binds, following doxycycline and leptomycin 
B treatment (Fig. 2B). In fact, when the DNA methylation status of these sites was compared at the genomic 
level between control and AID-expressing cells using methylation bead arrays we found no significant changes 
(Supplementary Figure 1B). Furthermore, the analysis of repetitive elements, such as Alu and LINE-1 repeats, 
also failed to find any changes (Supplementary Figure 1C and D), which rules out the existence of DNA demeth-
ylation events in association with AID binding, at least in this biological model.
We then performed ChIP assays with three different histone modifications, focusing on their association with 
the Sμ and Cμ regions. Specifically, we looked at H4K20me3, H3K27me3 and H3K4me3 (Fig. 2C). EZH2 and 
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Figure 1. An inducible system for AID expression and accumulation in the nucleus. (A) Representative scheme 
of the HA-tagged AID retroviral construct. (B) AID expression is induced following doxycycline (D) treatment 
and retained in the nucleus upon additional treatment with leptomycin B (L), which specifically inhibits nuclear 
export. Anti-HA antibody was used to detect AID expression and histone H3 was used as a loading control (C) 
Representative confocal images of AID subcellular localisation in HeLa and Jiyoye cells after doxycycline and 
leptomycin B treatment. Nuclear DNA was counterstained with DAPI (red). A total of 25 cells from randomly 
selected fields were analysed in each experimental condition. The graphs in the right show the quantification 
of the cellular signal of AID within the cells. Light gray section of the bar indicates the average percentage of 
cytoplasmic AID signal. Black section of the bar indicates the average percentage of nuclear AID signal. (D) 
Association of AID with heterochromatin. Time course digestion of HA-tagged AID Jiyoye cells nuclei with 
DNase I, in which the supernatant contains the euchromatin fraction (as demonstrated by the appearance 
of H3Ac and H3K4me3) and the pellet contains the heterochromatin fraction (as shown by the progressive 
decrease of H4K20me3 and H3K27me3).
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Figure 2. Effects of AID binding on the epigenetic status of the IGH locus. (A) Schematic representation of 
the IGH locus, and the participation of AID in class switch recombination and somatic hypermutation. Sμ 
and Cμ regions within this locus are bona fide binding and non-binding sites for AID and are used to test the 
effects of AID on epigenetic status. (B) Bisulphite pyrosequencing of the Sμ and Cμ regions in HeLa and Jiyoye 
cells transduced with the inducible retroviral system before (C) and after induction with doxycycline (D), and 
following inhibition of nuclear export with leptomycin B (DL). Each red bar shows the percentage of DNA 
methylation at a CpG site. 6 CpG sites were analysed at Sμ region, whereas 15 CpG sites were analysed at Cμ 
region (additional details in Supplementary Figure 1A). (C) AID association and selected histone modifications 
at the Cμ and Sμ regions using ChIP assays. AID was immunoprecipitated using anti-HA. ChIP assays also 
included H4K20me3, H3K27me3, H3Ac, H3K4me3 at the Cμ and Sμ regions. IgG was used as a negative 
control. For HeLa and Jiyoye cells we used control (C), doxycycline (D), and doxycycline +leptomycin B 
conditions (DL). Y-axis shows the relative enrichment of bound fraction with respect to input fraction. (D) 
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H3K27me3 modulate chromatin structure in B cell differentiation22. On the other hand, B-cell-specific condi-
tional knockouts for the Suv4-20h1 and Suv4-20h2 genes, encoding for the enzymes that are mainly responsible 
for the balance between H4K20me3 and H4K20me2 results in defective in CSR, suggesting potential links to 
AID19.
We observed specific enrichment of H4K20me3 at Sμ but not at Cμ regions, both in Jiyoye B cells and HeLa 
cells following expression of AID and translocation to the nucleus (Fig. 2C) concomitant with the specific bind-
ing of AID to Sμ sequences previously demonstrated. Regarding H3K4me3, we also observed changes in Jiyoye B 
cells but not in HeLa cells. H3K27me3 was present in the Sμ and Cμ regions of HeLa cells but not in Jiyoye cells.
To determine whether changes in H4K20me3 also occurred at the global level we performed western blot 
assays with Jiyoye cells before and after induction with doxycycline. No changes at the global level were observed 
for H3K27me3 and H3K4me3 (Fig. 2D). We found a significant increase in H4K20me3 following AID induc-
tion, reinforcing the notion of a direct role of AID in producing an increase in this modification at its bind-
ing sites (Fig. 2D). Because of this global effect together with the potential role of Suv4-20 family members in 
CSR, we decided to explore a mechanistic link between AID and the methyltransferases responsible for H4K20 
methylation.
Transfected AID interacts with Suv4-20 family proteins and recruits them to chromatin in 293F 
cells. Changes in H4K20me3 following binding of AID may suggest an association between AID and the 
recruitment of histone methyltransferases of the Suv4-20 family. As aforementioned, there are two genes in this 
family, SUV420H1 and SUV420H2, the first of which produces two isoforms, SUV4-20H1.1 and SUV4-20H1.2, 
through alternative splicing (Fig. 3A). SUV4-20H1.1 and SUV4-20H1.2 are mainly H4K20 dimethyltransferases 
(monomethylation is achieved through PR-SET7) and SUV4-20H2 is involved in the transition from dimethyl 
to trimethyl H4K20 and is a major constituent of heterochromatin23. We performed co-immunoprecipitation 
experiments to explore the potential physical interactions between these enzymes and AID (Fig. 3A).
In these experiments, we used an alternative cell system 293F, which allows the efficient co-transfection of 
tagged SUV4-20H proteins and AID, and leads to the co-expression of the C-t FLAG-tagged AID along with an 
HA-tagged version of each of the SUV4-20 enzymes. The use of this alternative model allows us to test each SUV4-
20 enzyme individually because there are no specific antibodies for the three of them. These experiments revealed 
that AID interacts with the three SUV4-20H proteins, as demonstrated by immunoprecipitation of Flag-tagged 
AID and the reciprocal experiment immunoprecipitating with HA-tagged SUV4-20H proteins (Fig. 3B).
We then investigated the association of the SUV4-20H enzymes with the IgH Sμ and Cμ sites in relation to 
AID expression in these cells. ChIP experiments revealed that SUV4-20H1.1 is associated with the IGH Sμ region 
only in the absence of AID (Fig. 3C). Furthermore, co-transfection with AID impairs its association with the Sμ 
and Cμ sites (Fig. 3C). In the case of SUV4-20H1.2, we observed a similar behaviour, although this enzyme only 
associates with the Sμ site (Fig. 3C). Most importantly, we found that SUV4-20H2 only associates with the Sμ site 
in the presence of AID, suggesting a role for AID in recruiting this enzyme to the chromatin in these regions.
Since H4K20me3 is a mark of heterochromatin, we decided to investigate the potential impact of AID on 
accessibility at the IgH locus using DNaseI digestion followed by amplification by quantitative PCR with primers 
for the Cμ and Sμ sequences. We cut the DNase-resistant fraction (size range ≥5000 bp) at different times and 
amplified the aforementioned sequences. This strategy allowed us to monitor the dynamics of digestion and to 
estimate the accessibility to DNase. Analysis of these sequences in the Jiyoye cells inducible for AID expression 
revealed that the Cμ site and non-satellite subtelomeric repeats (D4Z4) are less accessible to DNase than the Sμ 
site or an active gene like c-Fos, which was used as a positive control. However, no differences were observed with 
respect to the expression or nuclear presence of AID (Fig. 3D).
We also checked whether AID association and binding to the Sμ IgH affects the levels of the transcription 
produced by the TSS related to this site, assessed by quantitative RT-PCR. No differences were seen with respect 
to the expression of AID (Fig. 3E).
HIGM2 AID truncated form W68X is impaired for efficient binding to SUV4-20H1.2 and SUV4-
20H2. Our experiments demonstrated that AID and SUV4-20H enzymes can interact, and the effects of such 
interaction at Sμ sites. We wondered whether these interactions are impaired in the context of HIGM2 mutations. 
These experiments not only help us understand the functional implications of these mutations but also can help 
tease apart the roles of different domains in establishing these interactions. To this end, we generated a version 
of the AID-inducible system in HeLa and Jiyoye cells for several HIGM2 forms, including AID R24W, W68X, 
C87R, M139V, R174S and R190X (Fig. 4A). R24W AID is mutated in the nuclear localisation signal (NLS), W68X 
and C87R are, respectively, a nonsense and a missense mutation at the catalytic domain of AID. W68X produces 
a severely truncated protein (Fig. 4B). M139V and R174S are both missense mutations outside any known func-
tional domain of AID. Finally, we also tested R190X AID, a nonsense mutant form that generates a shorter protein 
without part of the nuclear export signal (Fig. 4B). Interestingly, this region has recently been found to participate 
in recruiting DNA damage response factors17.
To test our mutants, we first investigated their cellular localization by immunofluorescence and confocal 
microscopy using a rabbit monoclonal anti-HA antibody. As mentioned above, wild-type AID is expressed fol-
lowing treatment with doxycycline and accumulates in the nucleus after leptomycin B treatment in HeLa and 
Effects of AID on the global content of H4K20me3, H3K4me3 and H3K27me3 of Jiyoye cells as determined by 
western blot (left panel) and quantitation (right panel) of three independent experiments. Mock-infected cells 
were used as an additional negative control. Concomitantly with AID overexpression, the levels of H4K20me3 
increased significantly (t- test p < 0.01) whereas H3K4me3 and H3K27me3 were unaffected.
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Figure 3. AID interacts with SUV4-20H enzymes and recruits them to IgH Sμ regions (A) Scheme depicting 
immunoprecipitation experiments of 293F cells co-transfected with Flag-tagged AID and each of the HA-
tagged SUV4-20H enzymes: SUV4-20H1.1, SUV4-20H1.2 and SUV4-20H2. AID was also transfected on its 
own. Material immunoprecipitated with anti-HA was then blotted and visualised with anti-FLAG to determine 
its potential interaction with AID. The reciprocal experiment was also performed, using anti-FLAG to 
immunoprecipitate AID and anti-HA was used to test the interaction with each of the SUV4-20H enzymes.  
(B) Western blot assays showing the results of the above experiment (C) ChIP assays showing the recruitment of 
AID and SUV4-20H enzymes at the Cμ and Sμ regions. 293F cells were co-transfected or not with AID-FLAG 
construct plus the different SUV4-20H-HA enzymes constructs. After 24 hours, cells were fixed, lysed and 
chromatin sonicated to perform ChIP assays with control IgG, anti-FLAG antibody to immunoprecipitate AID 
or anti-HA antibody to pull down SUV4-20H enzymes. The upper section shows the association of SUV4-20H 
enzymes with the Sμ and Cμ regions. Light gray bars indicate the relative enrichment of SUV4-20H enzymes 
(HA antibody) with respect to input fraction. White bars represent negative control of enrichment (IgG). Lower 
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Jiyoye cells (Fig. 4C and Supplementary Figure 2). The R24W, C87R, M139V AID mutants had a similar behav-
iour to wild type AID, although the two truncated forms of AID, W68X and R190X, which contain the nuclear 
import signal but lack the nuclear export and cytoplasmic retention signals, accumulated in the nucleus constitu-
tively20, 24 (Fig. 4C and Supplementary Figure 2).
We then tested the ability of these mutant forms of AID to interact with SUV4-20H enzymes. 
Co-immunoprecipitation experiments with the anti-FLAG antibody in cells co-transfected with HA-tagged AID 
and each of the three SUV4-20H enzymes showed that wild type AID and all the mutant forms can interact 
with SUV4-20H1.1, SUV4-20H1.2 and SUV4-20H2. The AID-truncated form, W68X, which lacks two thirds 
of the protein, was significantly impaired for binding for all SUV4-20 enzymes (Fig. 4D). Other mutant forms 
appeared to have various degrees of interaction, compared to wild type AID, however we were unable to have 
conclusive results for these other mutants due to interexperimental variation. These results indicated that the 
W68X form of AID might be unable to recruit SUV4-20H2 to Sμ sites. We therefore tested the ability of W68X to 
target H4K20me3 at the Sμ site in comparison with wild type AID. In ChIP experiments, we observed that, after 
induction with doxycyclin and LMB, the W68X AID form is unable to bind to the Sμ site of the IGH locus, in 
contrast with wild type AID. Consistently, no enrichment for H4K20me3 was observed for W68X AID (Fig. 4E), 
reinforcing the notion that H4K20me3 enrichment is associated with AID targeting of SUV4-20H2 to the Sμ site.
AID targets H4K20me3 at Sμ in mouse primary B cells undergoing CSR. Finally, to prove the 
relevance of our findings in primary B cells that are able to undergo CSR, we isolated resting B cells from both 
wild type C57BL6/J and Aicda knockout (Aicda−/−) mice and compared the ability of these cells to acquire 
H4K20me3 at the IgH locus (including Sμ sites) upon LPS- and IL-4-induced activation. LPS and IL-4 induced 
CSR to IgG1 in around 16.5% cells towards (measured as IgG1+ cells) in wild type B cells, whereas only a 
background 0.71% B cells were IgG1+ in Aicda−/− mice (Fig. 5A). ChIP analysis of those cells showed that 
H4K20me3 is highly enriched in LPS/IL-4-activated WT B cells at Sμ upstream site of LPS/IL-4-activated wild 
type B cells, where binding of AID has been previously described25 and such enrichment was significantly reduced 
in LPS/IL4-activated Aicda−/− B cells (Fig. 5B), demonstrating that AID presence or activity is associated to the 
occurrence of this modification.
We also performed ChIP assays using the mouse lymphoma cell line CH12F3-2, capable of efficient in vitro 
cytokine-induced AID expression and CSR to IgA through the same molecular mechanisms used by primary 
lymphocytes. We compared the H4K20me3 levels at the Sμ site in CH12F3-2 (CH12) cells before and after acti-
vation, in stable AID-knockdowns of CH12F3-2 cells (shAID-CH12) and shAID-CH12 re-infected with AID 
(shAID + AID-CH12). Knockdown and reintroduction of AID resulted respectively in reduction and increase 
CSR to IgA (Fig. 5C). In ChIP assays, we observed an increase of H4K20me3 at the Sμ site, which was respectively 
decreased and increased in parallel with the knockdown and reintroduction of AID (Fig. 5D), supporting further 
the role of AID in targeting H4K20me3 changes.
Discussion
Our results demonstrate a novel relationship between AID and SUV4-20H enzymes that changes the H4K20 
methylation status at the Sμ sites of the IgH locus. This result provides a novel link between AID and SUV4-20H 
histone methyltransferases that explains previous observations on the effects on CSR of knocking out Suv4-20h 
enzymes in mice19. The existence of such changes in the methylation status of H4K20 at these sites suggests a role 
for this process that is relevant to CSR and perhaps to SHM. Our results of AID HIGM2 mutants suggests that 
that the physical presence of AID contributes to recruit SUV4-20H2 to the Sμ sites. Changes in the H4K20me3 at 
the IGH locus are relevant in primary B cells undergoing CSR, and the loss of AID is accompanied by reduction 
in H4K20me3 levels at Sμ sites. Of note, the latter results also show that there is also AID-independent deposition 
of this mark at the S region. Our model system also revealed the lack of effects on DNA methylation, suggesting 
that the contribution of the cytidine deaminase activity of AID in DNA methylation, if any, is restricted to specific 
situations and is not simply associated with its high level of expression, but perhaps is more closely related to 
differentiation processes.
One of the most significant findings of our study is the identification of the link between AID and H4K20 
methylation changes. H4K20 methylation is a chromatin modification that has been linked with diverse epige-
netic functions. Enzymes responsible for H4K20 methylation are members of the SUV4-20H family, in which 
SUV4-20H1.1 and SUV4-20H1.2 are associated with H4K20 mono- and dimethylation and SUV4-20H2 catalyses 
H4K20 trimethylation. The generation of conditional null alleles for the two Suv4-20h histone methyltransferase 
section of the figure shows the association of AID with the Sμ and Cμ regions. Blue bars indicate the relative 
enrichment of AID (FLAG antibody) with respect to input fraction. White bars represent negative control 
of enrichment (IgG). (D) DNA accessibility assay. Amplification by quantitative PCR of Sμ, Cμ, D4Z4 and 
c-fos regions after DNAse I digestion. Accessibility is represented as the ratio among the final reaction point 
(30 minutes) and the initial reaction point (1 minute). It was possible to detect variations in DNA accessibility 
levels as demonstrated by the differences detected among D4Z4 and c-fos regions, but it was not detected 
variations in DNA accessibility after AID overexpression and its nuclear accumulation. This experiment was 
carried out with Jiyoye cells transduced with empty vector (Mock) or with AID encoding vector. The DNA 
accessibility was assessed in these cells after treatment with doxycycline (D) or doxycycline + LMB (DL). (E) 
μGLT expression after AID overexpression and nuclear accumulation. The μGLT expression was normalized 
to RPL38 expression. Ramos cells were used as a positive control of μGLT expression, whereas Jiyoye sample 
processed without retrotranscriptase was used as a control of genomic DNA contamination.
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Figure 4. Effects of HIGM2 mutant forms of AID on cell distribution and interaction with SUV4-20H 
enzymes. (A) Primary structure of AID. The upper part of the diagram indicates the four missense mutations 
related to HIGM2used in our study. The lower part indicates the two selected nonsense HIGM2 mutations. 
NLS, nuclear-localisation signal; CDD, cytidine deaminase domain; NES, nuclear-export sequence. (B) Western 
blot image showing the inducible expression of AID WT and the various HIGM2 mutants, before and after 
treatment with doxycycline 500 ng/ml for 48 hours. (C) Representative confocal images showing the subcellular 
localisation of C-terminally hemagglutinin (HA)-tagged human AID in inducible HeLa cells. A total of 20 
cells from randomly selected fields were analysed in each experimental condition. The graphs next to the 
confocal images, show the quantification of the cellular signal of AID within the cells. Light gray section of the 
bar indicates the average percentage of citoplasmic AID signal. Black section of the bar indicates the average 
percentage of nuclear AID signal. When nuclear export was inhibited with 50 ng/ml leptomycin B (LMB) for 
2 hours, most of the AID translocates from the cytoplasm to the nucleus. Protein products of missense HIGM2 
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genes in the mouse has been used to investigate the roles of H4K20 methylation states. Interestingly, Suv4-
20h-double-null (dn) mice, which lose nearly all H4K20me3 and H4K20me2 states, are defective in immunoglob-
ulin CSR, and this deficiency impairs the stem cell pool of lymphoid progenitors19. These results are consistent 
with our own finding of the direct participation of AID in the recruitment of SUV4-20H enzymes to CSR sites.
Several lines of evidence point to the epigenetic mechanisms as being key regulators of the events associated 
with antibody affinity maturation. SHM and CSR involve important alterations in DNA structure, and epigenetic 
mechanisms have been shown to be crucial not only for the establishment of the proper DNA conformation dur-
ing these processes, but also for the recruitment of the necessary machinery.
The targeting of AID activity to specific DNA regions has been one of the most intensively studied aspects of 
B cell activation, yet it is still far from fully understood. Most of the research efforts related to epigenetic mecha-
nisms and antibody affinity maturation have focused on describing the epigenetic landscapes that contribute to 
AID targeting and binding of CSR and SHM and, accordingly, AID recruitment has been associated with specific 
histone marks and specific DNA methylation patterns.
Our first observation was that, following DNase I chromatin digestion, AID presented a similar release pattern 
to that exhibited by the H4K20me3 heterochromatic mark. It is well established that AID is targeted to actively 
transcribed open chromatin regions, and its localisation is associated with active histone marks26, so we expected 
to see a coincidence of the release pattern of AID with the active histone marks represented by H3K4me3 and 
H3Ac in our experiment. Unexpectedly, AID was absent from the soluble fraction of DNase I digestion and 
mirrored the pattern of release of H4K20me3 in the insoluble fraction of the digestion. This fraction is not only 
associated with constitutive heterochromatin, but also contains regions of chromatin associated with large mul-
timeric (transcriptional and DNA-repair) protein complexes27, which we presume are the regions that explain 
the partitioning of AID in this fraction. To date, many histone modifications have been shown to modulate the 
recruitment of AID to the Ig and AID expression correlates with changes in the acetylation of histones at the S 
regions. However, this is the first description of AID directly recruiting a histone modifying enzyme that affects 
the epigenetic status of the Ig locus.
Our results demonstrate a direct interaction between AID and SUV4-20H enzymes. This has been demonstrated 
in 293F cells, given the limited co-transfection levels of AID and SUV4-20H in B cells. Analysis of HIGM2 AID 
mutant forms reveals that these interactions can be lost in severe truncated forms like W68X. While in some cases, 
interactions with AID have been demonstrated to take place at its N-t, including the histone chaperone Spt628, most 
interactions occur at the AID C-t, including those with the 14-3-3 adaptor proteins8, the translation elongation fac-
tor 1 alpha (eEF1A)29, or the germinal center-associated nuclear protein30. In the case of the W68X AID form, the 
loss of interaction with SUV4-20H1.2 and SUV4-20H2 suggests that the amino acid motifs after residue 68 of AID 
are necessary to interact with these enzymes and target H4K20me3 at the switching regions. There are additional 
evidences on the direct role of AID to target histone modifications to S regions, also in the context of B cell activa-
tion. For instance, AID-deficient B cells showed reduced levels of acetylation in H3 and H4 histones in S regions. 
Thus, the increase of H3Ac and H4Ac levels observed during B cell activation depends on AID expression10.
The increase in the H4K20me3 levels induced by AID overexpression in our cell system did not result in a 
change in the accessibility of S regions or alterations in the transcription of the μGLT. Therefore, there is no clear 
evidence of the role of this change during CSR. Recently, it has been proposed that hMOF-mediated H4K16Ac 
and SUV4-20H2-mediated H4K20me3 play opposing roles in the regulation of Pol II pausing. H4K16Ac pro-
motes the release of Pol II from pausing, whereas Pol II remains paused in the presence of H4K20me331. It is 
well known that the stalling of Pol II is a crucial step for AID targeting. Stalled Pol II not only acts as a docking 
protein for AID recruitment through Spt5 interaction32, but also facilitates the recruitment of histone modifiers to 
produce the accessibility required for AID activity. On the basis of these findings, we suggest that AID reinforces 
the stalling of Pol II by recruiting SUV4-20H2 and the increase of H4K20me3 levels in the Sμ region, thereby 
generating a positive feedback loop that reinforces its recruitment to mediate CSR. Further research is required 
to confirm this hypothesis.
Our results provide evidence of a novel AID role beyond its catalytic activity during antibody affinity matura-
tion. The discovery of AID partners and the function of the variety of interactions established by AID is a crucial 
step towards fully understanding the additional roles of this enzyme during CSR and SHM, and also in B cell 
differentiation and maturation.
Methods
Human Cells. The human cell lines used in this study were grown in a humidified incubator at 37 °C and 5% 
CO2 and were maintained in log phase growth by changing the culture medium every 48–72 hours. The Burkitt 
lymphoma-derived cell line Jiyoye was cultured in RPMI medium supplemented with 5% FBS (v/v) and antibi-
otic/antimycotic solution; adherent HeLa and 293F cell lines were grown in DMEM medium with 5% FBS (v/v) 
and antibiotic/antimycotic solution.
mutations showed a similar response to AID WT after LMB, while truncated forms of AID lacking NES were 
constitutively nuclear. Scale bar: 10 μm. (D) Co-immunoprecipitation of AID WT and HIGM2 mutants with 
the three SUV4-20H enzymes. All the HIGM2 mutants were also able to interact with the three SUV4-20H 
enzymes. (E) ChIP assays showing the recruitment of wild type AID (WT) and W68X AID mutant (W68X) 
and H4K20me3 enrichment at the Cμ and Sμ regions in Jiyoye cells after doxycycline and LMB treatment for 
24 hours. AID was immunoprecipitated using anti-HA and ChIP assays also included anti-H4K20me3 antibody 
and IgG as a negative control. Y-axis shows the relative enrichment of bound fraction with respect to input 
fraction.
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Mouse B cells and CSR. Resting B cells were purified from spleens of C57BL6/J mice or Aicda−/− mice 
(obtained from T. Honjo, Kyoto University, Sakyo-ku, Kyoto, Japan) as described previously24. Briefly, leuko-
cytes were purified by densitiy cushion using Lympholyte-M (Cedarlane Labs), stained anti-CD43 microbeads 
(Miltenyi Biotech) and depleted of CD43+ cells using autoMACS Pro Separator (Miltenyi Biotech). The puri-
fied B-cells were plated at 0.5 × 106 cells/ml and activated with 5 µg/ml LPS (Sigma) and 30 ng/ml recombinant 
murine IL-4 (Preprotech) for switching to IgG1. For ChIP, primary cells were cross-linked 48 h after activation 
as described below. In primary B cells. CSR was analyzed 72 h after activation by flow cytometry. Cells were 
incubated with FcR Blocking Reagent for mouse (Miltenyi Biotech); then stained with anti–IgG1-biotin (BD), 
followed by APC-conjugated anti-biotin antibody (Miltenyi Biotech). Dead cells were excluded from this analysis 
by propidium iodide staining.
Mouse CH12F3-2 cells were plated at 0.1 × 106 cells/ml and activated with 1ng/ml recombinant human 
TGF-β1 (R&D systems), 10ng/ml recombinant murine IL-4 (Preprotech), and 1 µg/ml functional grade purified 
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Figure 5. Role of AID in H4K20me3 deposition at IgH locus in switching primary B cells. (A) Primary B cells 
were isolated from wild type (WT) or Aicda−/− mice and then activated with LPS (5 μg/ml) and IL4 (30 ng/
ml) for 3 days. After that, cells were stained to check class-switch recombination to IgG1. (B) Cells were also 
fixed, lysed and chromatin sonicated to perform ChIP assays with control IgG or anti-H4K20me3 antibodies. 
H4K20me3 deposition at IgH locus was analyzed using primers for specific regions where AID binding has 
been previously reported. Y-axis shows the relative enrichment of bound fraction with respect to input fraction. 
(C) Mouse CH12F3-2 cells were activated with 1ng/ml recombinant human TGF-β1, 10 ng/ml recombinant 
murine IL-4, and 1 µg/ml functional grade purified anti–mouse CD40 for switching to IgA. Additionally, 
CH12F3-2 cells stably expressing shRNA against mouse AID were complemented with human AID by 
retroviral transduction and then activated in the same conditions. CSR was analyzed 72hrs after activation by 
flow cytometry, after staining cells with Anti-Mouse IgA-PE and propidium iodide, for excluding dead cells. (D) 
For ChIP, CH12F3-2 cells were also fixed, lysed and chromatin sonicated to perform ChIP assays with control 
IgG or anti-H4K20me3 antibodies. H4K20me3 enrichment at IgH locus was analyzed using primers for specific 
regions where AID binding has been previously reported. Y-axis shows the relative enrichment of bound 
fraction with respect to input fraction.
www.nature.com/scientificreports/
1 1SCIEntIFIC REPoRtS | 7: 7594  | DOI:10.1038/s41598-017-07380-9
anti–mouse CD40 (BD) for switching to IgA. Additionally, CH12F3-2 cells stably expressing shRNA against 
mouse AID (gift from R. Verdun, University of Miami, Florida, Miami, USA) were complemented with human 
AID by retroviral transduction using the supernatant of HEK293 cells co-transfected with vectors encoding 
VSV-G and GAG-Pol and either the empty pMX-IRES-GFP vector or pMX-kozak-AID-IRES-GFP vector encod-
ing AID. For ChIP, CH12F3-2 cells were cross-linked 24hrs after activation as described below. In CH12F3-2 cells, 
CSR was analyzed 72hrs after activation by flow cytometry, after staining cells with Anti-Mouse IgA-PE (Southern 
Biotech) and propidium iodide, for excluding dead cells.
DNA constructs and the system for inducible AID expression. A C-terminally haemagglutinin (HA)- 
tagged AID was generated by PCR amplification with the forward primer 5′-ATGGATCCAGACACTC 
TGGACACCACTATG-3′ and reverse primer 5′-TAGAATTCCTAAGCGTAATCTGGAACATCGTA-3′. The 
forward and reverse primers respectively introduced a BamHI and an EcoRI site. The amplified fragment corre-
sponding to AID WT was then cloned into BamHI/EcoRI-digested pRetroX-Tight-Pur vector. The AID mutants 
were generated by the Quickchange method (Stratagene) using the primers listed in Supplementary Table 1. To 
generate the inducible expression of AID we used the Retro-XTM Tet-ON® Advanced Inducible Expression System 
(Clontech). Firstly, Jiyoye and HeLa cell lines were transduced with the RetroX-Tet-ON advanced vector and 
geneticin selected at 1 mg/ml (Life Technologies). Secondly, cells were transduced with the pRetroX-Tight-Pur 
vector encoding AID and selected with puromycin (Sigma-Aldrich) at 0.3 µg/ml for Jiyoye cells and 3 µg/ml for 
HeLa cells. AID expression was induced by the addition of doxycycline (Clontech) at 500 ng/ml to the culture 
media for 24 hours for Jiyoye cells and 48 hours for HeLa cells. Nuclear export was inhibited by the addition of 
leptomycin B (LMB) (LC labs) for 2 hours at 10 ng/ml for Jiyoye cells and 50ng/ml for HeLa cells as previously 
described20. The experimental procedures with the inducible system for AID expression were carried out under 
four conditions: (1) Control (C): Cell lines without AID expression; (2) Doxycycline (D): Cell lines after doxy-
cycline treatment to induce AID expression; (3) Doxycycline + LMB (DL): Doxycycline and LMB treatment to 
induce AID expression and its nuclear accumulation; and (4) Control + LMB (CL): Cell lines with LMB.
Western blot. Proteins were separated on 15% or 8% SDS-PAGE gels and blotted onto a polyvinylidene 
difluoride membrane of 0.22-µm or 0.45-µm pore size (Immobilon PSQ, Millipore) according to the size of 
the protein analysed. The membrane was blocked in 5% milk TBS-T (Tris-buffered saline with 0.1% Tween-
20) and immunoprobed with the antibodies listed in Supplementary Table 2. The secondary antibodies used 
were goat anti-rabbit-conjugated to horseradish peroxidase (HRP) (1:10,000–1:30,000) (Amersham) and sheep 
anti-mouse-HRP (1:5000). Experiments were performed in triplicate. Bands were quantitated by direct scanning 
of the western blot films with an HP Scanjet 4890 and processed with ImageJ software. Where indicated, a student 
t-test was applied to compare the levels of the analysed proteins (statistical significance *p < 0.01).
Immunofluorescence and confocal microscopy. Immunofluorescence experiments were carried out as 
previously described20 with slight modifications. Briefly, the transduced the Jiyoye cell line was plated in a 24-well 
plate and allowed to attach to poly-lysine-coated coverslips for 15 min at 37 °C in PBS. HeLa cells were plated in 
a 6-well plate and allowed to attach to coverslips 24 hours before AID expression induction. After this time the 
cells were fixed with 4% paraformaldehyde, permeabilised in 0.5% (v/v) Triton X-100 and blocked with 1 mg/ml 
BSA + 5% goat normal serum in PBS. Both cells types were stained with anti-HA (1:200; Sigma-Aldrich) followed 
by anti-rabbit AlexaFluor 488 (1:1000; Life Technologies). Stained preparations were mounted in Mowiol-DAPI 
mounting medium and confocal optical sections were obtained using a Leica TCS SP5 Spectral confocal micro-
scope (Leica Microsystems). Images were acquired with Leica Application Suite Advanced Fluorescence (LAS 
AF) software and processed with ImageJ software. Each immunofluorescence experiment was performed inde-
pendently at least two times.
DNAse I digestion-based assay. With this assay we followed the release of AID and various histone marks 
after DNase I digestion. The digestion was carried out in nuclei isolated from the Jiyoye cell line after treatment 
with doxycycline and LMB to induce AID overexpression and nuclear accumulation, respectively. Cell cytoplasms 
were disrupted with RSB buffer (10 mM Tris-HCl pH 7.5, 10 mM NaCl, 3 mM MgCl2). The isolated nuclei were 
then washed and resuspended in DNase I buffer before adding DNase I to initiate DNA digestion at 37 °C. We 
monitored the time course of DNase I-induced release of AID and histone proteins after 2, 4, 8, 16 and 32 minutes 
of digestion. The reaction was stopped by adding EDTA 0.5 mM. These procedures were carried out in the pres-
ence of Roche Complete Protease Cocktail Inhibitor.
Sensitivity to nuclease digestion is determined by chromatin structure. After DNase I digestion it is possible to 
isolate a highly nuclease-accessible chromatin fraction and a DNase-resistant fraction. The highly accessible chro-
matin fraction (soluble fraction) is mainly associated with active genes and therefore with activation-associated 
histone marks, whereas the DNase-resistant fraction (insoluble fraction) is mainly associated with constitutive 
heterochromatin and regions of chromatin associated with large multimeric (transcriptional and DNA-repair) 
protein complexes27.
From the samples taken at each digestion time we obtained soluble and insoluble protein fractions and sub-
jected them to western blot analysis to determine the pattern of appearance or disappearance of AID and the 
specific histone marks H3K20me3 (heterochromatin mark), H3K27me3 (facultative heterochromatin mark), and 
H3K4me3 and acetylated H3 (euchromatin marks).
Bisulfite pyrosequencing of Sμ and Cμ at the IGH locus. The DNA methylation status of the Sμ and 
Cμ regions, was determined by pyrosequencing fragments of 331 bp and 215 bp respectively (Supplementary 
Figure 1). Biotinylated amplicons for each gene region were generated by PCR using the HotStart Taq DNA 
www.nature.com/scientificreports/
1 2SCIEntIFIC REPoRtS | 7: 7594  | DOI:10.1038/s41598-017-07380-9
polymerase PCR kit (Qiagen). Specific primers were designed using the PyroMark Assay Design Software 
(QIAGEN- version 2.0.01.15). Pyrosequencing reactions and quantification of DNA methylation were performed 
with Pyromark™ Q24 system (Qiagen). Results from bisulfite pyrosequencing are presented as a percentage of 
DNA methylation. Primers are listed in Supplementary Table 1.
Expression of μ Germline transcripts. To analyze the expression of μ Germline transcripts (μGLT) of the 
IGH locus, we isolated total RNA with Trizol® Reagent (Life Technologies). Then, mRNA was retrotranscribed 
with the Transcriptor First Strand cDNA Synthesis Kit (Roche). cDNA synthesis reaction was carried out by using 
anchored oligo(dT)18 primer, especially designed to enrich the retrotranscription of mRNAs. We analyzed the 
expression of mature μGLT by amplifying a 106 bp region within the non-coding Iμ exon. cDNA from Ramos 
cell line, which is another Burkitt’s lymphoma derived cell line, and RNA from Jiyoye processed without reverse 
retrotranscriptase, were used as a positive and negative control respectively. The μGLT expression was analyzed 
by real-time PCR. The results were normalized to the RPL38 (Ribosomal protein L38) expression, and referred to 
the expression of control Jiyoye cells (without doxycycline or LMB treatment).
Chromatin immunoprecipitation. The chromatin immunoprecipitation assays were carried out as 
previously described33. Immunoprecipitated material was analysed by quantitative real time PCR (see primer 
sequences in Supplementary Table 1). IgG was used as a negative control. Chromatin immunoprecipitation exper-
iments were performed independently at least two times. The antibodies used for these experiments are listed in 
Supplementary Table 2.
Immunoprecipitation. 293F cells were transfected using polyethylenimine (PEI) with the following plas-
mids: pCDNA3.1 constructs encoding the FLAG-tagged WT and mutant forms of AID and plasmids encoding 
the lysine 20 histone 4 methyltransferases, pCDNA4/T0Suv4-20h1.1-HA, pCDNA4/T0Suv4-20h1.2-HA and 
pCISuv4-20h2-HA34, 35. Whole cell extracts were obtained with RIPA buffer (50 mM Tris-HCl pH 7.8, 150 mM 
NaCl, 0.5% deoxycholic acid, 0.1% SDS, 1% NP40) and treated with benzonase 40U (Sigma-Aldrich) for 4 hours 
before immunoprecipitation. After this time, the samples were centrifuged for 10 minutes at 7000 g. The super-
natant was then diluted with BC-100 buffer (10 mM Tris-HCl pH 7.8, 0.5 mM EDTA, 0.1 mM PMSF, 1 mM DTT, 
50% glycerol, 100 mM KCl) and overnight incubated at 4 °C with FLAG-agarose (Sigma-Aldrich) for AID immu-
noprecipitation, or HA-agarose (Sigma-Aldrich) for SUV4-20H immunoprecipitation. The samples were washed 
twice with BC-100, 0.05% NP-40 and five times with BC-500 (50 mM Tris-HCl pH 7.8, 2.5 mM EDTA, 0.5 mM 
PMSF, 5 mM DTT, 50% Glycerol, 500 mM KCl), 0.05% NP-40. The immunoprecipitated proteins were eluted 
using 0.2 M glycine pH 2.3 and the resulting material was analysed by SDS-PAGE and western blot. The antibod-
ies used for these experiments are listed in Supplementary Table 2.
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